Verbert SRL
The score of Verbert shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verbert's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Sep 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Verbert's financial analysis
- Solvency98.2%sector median: 50.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verbert
Verbert's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0462.345.847
- VAT number
- BE0462345847
- Peppol
- Registered · 0208:0462345847 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jan 1998
- Registered office
- 2150 Antwerp
- Latest accounts
- 2025 · filed on 07 Sep 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Verbert (SRL) has been based in Antwerp since 1998, active in: manufacture of medicaments. For 2025, it reports a net profit of 67,651 € and equity of €2.65m; its revenue is not published. Its solvency stands at 98.2%, above the median of its sector (50.3%).
Companies similar to Verbert
Companies in the same business, of comparable size and area, outside its group.
- Curavac Europe Manufacture of basic pharmaceutical products Rixensart · balance sheet €2.53m
- FASE Manufacture of pharmaceutical preparations Nazareth-De Pinte · balance sheet €2.45m
- NeGIO Therapeutics Manufacture of basic pharmaceutical products Charleroi · balance sheet €4.76m
- Axo Industry International Manufacture of pharmaceutical preparations Wavre · balance sheet €1.63m
- Lifrank Manufacture of basic pharmaceutical products Wingene · balance sheet €4.07m
- Highstar Engineering Manufacture of pharmaceutical preparations Diepenbeek · balance sheet 342,212 €
- Temmune Therapeutics Manufacture of pharmaceutical preparations Mechelen · balance sheet €3.43m
- Pharmacura Activities of holding companies Ternat · balance sheet €2.30m
Frequently asked questions about Verbert
What is the revenue of Verbert?
Verbert files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Verbert?
In Belgium, the VAT number is the company number prefixed with BE: BE0462345847 for Verbert, if the company is VAT-registered. Its company number (CBE) is 0462.345.847.
Where is the registered office of Verbert?
According to the CBE register, the registered office of Verbert is in 2150 Antwerp.
What is the equity of Verbert?
At the close of the 2025 financial year, the equity of Verbert amounts to 2,651,366 €, a solvency of 98.2% of total assets.
Who manages Verbert?
The register lists 2 active mandates at Verbert. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verbert
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →